242 related articles for article (PubMed ID: 27649478)
1. BMP Signaling Mediated by BMPR1A in Osteoclasts Negatively Regulates Osteoblast Mineralization Through Suppression of Cx43.
Shi C; Zhang H; Louie K; Mishina Y; Sun H
J Cell Biochem; 2017 Mar; 118(3):605-614. PubMed ID: 27649478
[TBL] [Abstract][Full Text] [Related]
2. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
[TBL] [Abstract][Full Text] [Related]
3. Hyperthyroidism-driven bone loss depends on BMP receptor Bmpr1a expression in osteoblasts.
Lademann F; Rijntjes E; Köhrle J; Tsourdi E; Hofbauer LC; Rauner M
Commun Biol; 2024 May; 7(1):548. PubMed ID: 38719881
[TBL] [Abstract][Full Text] [Related]
4. Connexin43 and Runx2 Interact to Affect Cortical Bone Geometry, Skeletal Development, and Osteoblast and Osteoclast Function.
Buo AM; Tomlinson RE; Eidelman ER; Chason M; Stains JP
J Bone Miner Res; 2017 Aug; 32(8):1727-1738. PubMed ID: 28419546
[TBL] [Abstract][Full Text] [Related]
5. Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors.
Shi C; Iura A; Terajima M; Liu F; Lyons K; Pan H; Zhang H; Yamauchi M; Mishina Y; Sun H
Sci Rep; 2016 Apr; 6():24256. PubMed ID: 27048979
[TBL] [Abstract][Full Text] [Related]
6. SMAD1/5 signaling in osteoclasts regulates bone formation via coupling factors.
Tasca A; Astleford K; Blixt NC; Jensen ED; Gopalakrishnan R; Mansky KC
PLoS One; 2018; 13(9):e0203404. PubMed ID: 30188920
[TBL] [Abstract][Full Text] [Related]
7. Communication-dependent mineralization of osteoblasts via gap junctions.
Hashida Y; Nakahama K; Shimizu K; Akiyama M; Harada K; Morita I
Bone; 2014 Apr; 61():19-26. PubMed ID: 24389413
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of BMP2/4 signaling increases both osteoblast-specific marker expression and bone marrow adipogenesis in Gja1Jrt/+ stromal cell cultures.
Zappitelli T; Chen F; Aubin JE
Mol Biol Cell; 2015 Mar; 26(5):832-42. PubMed ID: 25568340
[TBL] [Abstract][Full Text] [Related]
9. Dual function of Bmpr1a signaling in restricting preosteoblast proliferation and stimulating osteoblast activity in mouse.
Lim J; Shi Y; Karner CM; Lee SY; Lee WC; He G; Long F
Development; 2016 Jan; 143(2):339-47. PubMed ID: 26657771
[TBL] [Abstract][Full Text] [Related]
10. Controversy of physiological vs. pharmacological effects of BMP signaling: Constitutive activation of BMP type IA receptor-dependent signaling in osteoblast lineage enhances bone formation and resorption, not affecting net bone mass.
Kamiya N; Atsawasuwan P; Joiner DM; Waldorff EI; Goldstein S; Yamauchi M; Mishina Y
Bone; 2020 Sep; 138():115513. PubMed ID: 32603910
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling.
Mishina Y; Starbuck MW; Gentile MA; Fukuda T; Kasparcova V; Seedor JG; Hanks MC; Amling M; Pinero GJ; Harada S; Behringer RR
J Biol Chem; 2004 Jun; 279(26):27560-6. PubMed ID: 15090551
[TBL] [Abstract][Full Text] [Related]
12. Disruption of bone morphogenetic protein type IA receptor in osteoblasts impairs bone quality and bone strength in mice.
Bao Q; Li A; Chen S; Feng J; Liu H; Qin H; Li J; Liu D; Shen Y; Zong Z
Cell Tissue Res; 2018 Nov; 374(2):263-273. PubMed ID: 29987355
[TBL] [Abstract][Full Text] [Related]
13. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
[TBL] [Abstract][Full Text] [Related]
14. The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.
Bordukalo-Nikšić T; Kufner V; Vukičević S
Front Immunol; 2022; 13():869422. PubMed ID: 35558080
[TBL] [Abstract][Full Text] [Related]
15. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro.
Subramaniam M; Gorny G; Johnsen SA; Monroe DG; Evans GL; Fraser DG; Rickard DJ; Rasmussen K; van Deursen JM; Turner RT; Oursler MJ; Spelsberg TC
Mol Cell Biol; 2005 Feb; 25(3):1191-9. PubMed ID: 15657444
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
[TBL] [Abstract][Full Text] [Related]
18. The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss.
Zappitelli T; Chen F; Moreno L; Zirngibl RA; Grynpas M; Henderson JE; Aubin JE
J Bone Miner Res; 2013 Nov; 28(11):2400-13. PubMed ID: 23606335
[TBL] [Abstract][Full Text] [Related]
19. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.
Kamiya N; Ye L; Kobayashi T; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
Development; 2008 Nov; 135(22):3801-11. PubMed ID: 18927151
[TBL] [Abstract][Full Text] [Related]
20. Defective signaling, osteoblastogenesis and bone remodeling in a mouse model of connexin 43 C-terminal truncation.
Moorer MC; Hebert C; Tomlinson RE; Iyer SR; Chason M; Stains JP
J Cell Sci; 2017 Feb; 130(3):531-540. PubMed ID: 28049723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
